Ivabradine in treatment of symptomatic heart failure and supraventricular tachycardias in patients under six months of age

BackgroundAlthough heart failure (HF) and supraventricular tachycardias (SVT) are associated with high morbidity and mortality in pediatrics, especially, in children under 6 months; the efficacy of available treatments is limited, requiring the use of off-label therapies. The aim of the study is to...

Descrición completa

Detalles Bibliográficos

Principais autores:	L. Gómez-Ganda, C. J. Parramón-Teixidó, G. Giralt-García, C. Fernández-García, Q. Ferrer-Menduiña, M. J. Cabañas-Poy
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Pharmacology
Assuntos:	heart failure ivabradine pediatrics tachycardia atrial tachycardia ectopic atrial tachycardia
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1502375/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!